The clinical stage of MM can be measured by serum markers, including β2-microglobulin, free light chain ratio, creatinine and C-reactive protein levels followed by confirmation with invasive biopsy of bone marrow [64]. Here, HLA-G is linked to Miyoshi myopathy.